SCHEMBL10150862

SCHEMBL10150862

C[C@H]1C[C@@H]2C[C@H]2CC/C=C/C(=O)Cc2cc(O)cc(O)c2C(=O)O1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F13A1 P00488 1/20 0.72
TGM2 P21980 1/20 0.72
HSP90AB1 P08238 4/20 0.53
GEMIN4 P57678 1/20 0.49
HSF1 Q00613 1/20 0.49
NPC1 O15118 1/20 0.49
MITF O75030 1/20 0.49
MAPT P10636 1/20 0.49
RAB9A P51151 1/20 0.49
ATM Q13315 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
MKNK2 Q9HBH9 5/20 0.48
CCNA2 P20248 3/20 0.48
CDK2 P24941 3/20 0.48
CCNA1 P78396 3/20 0.48
MKNK1 Q9BUB5 3/20 0.48
PLK4 O00444 2/20 0.48
CDK1 P06493 2/20 0.48
AXL P30530 2/20 0.48
FLT3 P36888 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10150866 1.00 F13A1 (0.72) F13A1TGM2HSP90AB1GEMIN4HSF1
SCHEMBL10150812 0.87 F13A1 (0.72) F13A1TGM2HSP90AB1GEMIN4HSF1
SCHEMBL10150871 0.86 F13A1 (0.60) F13A1TGM2HSP90AB1GEMIN4HSF1
SCHEMBL10150872 0.86 F13A1 (0.60) F13A1TGM2HSP90AB1GEMIN4HSF1
Monocillin Iii SCHEMBL10150121 0.86 HSP90AB1 (0.71) F13A1TGM2HSP90AB1GEMIN4HSF1
Monocillin Iii SCHEMBL10150122 0.86 HSP90AB1 (0.71) F13A1TGM2HSP90AB1GEMIN4HSF1
Monocillin Iii SCHEMBL10150575 0.86 HSP90AB1 (0.71) F13A1TGM2HSP90AB1GEMIN4HSF1
SCHEMBL10150868 0.85 F13A1 (0.58) F13A1TGM2HSP90AB1GEMIN4HSF1
SCHEMBL10150869 0.85 F13A1 (0.58) F13A1TGM2HSP90AB1GEMIN4HSF1
SCHEMBL10150860 0.85 F13A1 (0.58) F13A1TGM2HSP90AB1GEMIN4HSF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120077775-A1 MACROCYCLIC COMPOUNDS USEFUL AS INHIBITORS OF KINASES AND HSP90 LE CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2012-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120077775-A1 MACROCYCLIC COMPOUNDS USEFUL AS INHIBITORS OF KINASES AND HSP90 HSP90AB1, HSP90AA1, HSP90AB2P F13A1 3067/4885TGM2 3060/4885HSP90AB1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.